Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

Abstract Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI) algorithms, to be useful for COVID‐19 infection via proposed anti‐cytokine effects and as an inhibitor of ho...

Full description

Saved in:
Bibliographic Details
Main Authors: Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J Richardson, Vanessa Monteil, Volker M Lauschke, Ali Mirazimi, Sonia Youhanna, Yee‐Joo Tan, Fausto Baldanti, Antonella Sarasini, Jorge A Ross Terres, Brian J Nickoloff, Richard E Higgs, Guilherme Rocha, Nicole L Byers, Douglas E Schlichting, Ajay Nirula, Anabela Cardoso, Mario Corbellino, the Sacco Baricitinib Study Group
Format: Article
Language:English
Published: Springer Nature 2020-06-01
Series:EMBO Molecular Medicine
Subjects:
anti‐cytokine
anti‐viral
baricitinib
case series
COVID‐19
Online Access:https://doi.org/10.15252/emmm.202012697
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items